Deals of the day-Mergers and acquisitions

Tokyo Kikai Seisakusho

17/11/2021 11:00

(Adds: Partners Group, Semantix, Tokyo Kikai Seisakusho,
NextEnergy Capital)
    Nov 17 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1530 GMT on Wednesday:
    
    ** Partners Group  PGHN.S  said it was acquiring U.S.
heating, ventilation and air conditioning parts maker
DiversiTech from private equity group Permira in a transaction
that values Diversitech at $2.2 billion.  urn:newsml:reuters.com:*:nFWN2S80LQ
    
    ** Brazil's Semantix said it would go public in the United
States by merging with a blank-check firm in a deal valuing the
data software company at about $1 billion.  urn:newsml:reuters.com:*:nL4N2S82TH
    
    ** Japan's Tokyo Kikai Seisakusho Ltd  6335.T  said it would
put on hold its planned use of a 'poison pill' takeover defence
measure against top shareholder Asia Development Capital (ADC)
 9318.T  as the fund offered to lower its stake to 32.72%.
 urn:newsml:reuters.com:*:nL1N2S80Y4
    
    ** Investment fund NextEnergy Capital has hired Rothschild
and Banca IMI to help it find a buyer for solar power plants in
southern Italy it hopes can fetch more than 400 million euros
($453 million), people familiar with the matter told Reuters.
 urn:newsml:reuters.com:*:nL8N2S734V
    
    ** London-listed miner Glencore  GLEN.L  has agreed to sell
its Ernest Henry Mining copper-gold mine in Queensland to
Australia-based Evolution Mining  EVN.AX  for A$1 billion
($729.60 million), the companies said. urn:newsml:reuters.com:*:nL4N2S81PL

    ** Africa's largest mobile operator MTN Group  MTNJ.J  said 
it will sell and leaseback more than 5,000 towers in South
Africa to London-based IHS Towers for 6.4 billion rand ($412
million) to help lower costs.  urn:newsml:reuters.com:*:nL1N2S809V
    
    ** U.S. buyout fund Carlyle said it had agreed to acquire
Swiss industrial software firm AutoForm AG from private equity
firm Astorg for an undisclosed amount.  urn:newsml:reuters.com:*:nL8N2S81OT
    
    ** Caledonia Investments said  that shareholders in its
drug-research services provider BioAgilytix agreed to sell
control of the company to private equity firm Cinven in a deal
that is expected to complete in December.  urn:newsml:reuters.com:*:nASN001WAR

 (Compiled by Rajarshi Roy and Amruta Khandekar in Bengaluru)
 ((Amruta.Khandekar@thomsonreuters.com))